+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 12Months - 14Years
All Genders
ID05478720

Safety Evaluation of Single Intravenous Dose of DON in Adults and Children with Cerebral Malaria Using Dose Escalation and Placebo-Controlled Design

Led by Douglas Postels, MD, MS · Updated on 2026-10-23

152

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effects of a single intravenous dose of 6-diazo-5-oxo-L-norleucine DON in healthy adults, adults with uncomplicated malaria, and children aged 12 months to 14 years with cerebral malaria. This study includes two parts an open-label dose escalation in adults and a randomized, placebo-controlled dose escalation in children with cerebral malaria, aiming to understand safety, pharmacokinetics, and potential effects on brain blood flow, brain volume, and brain activity patterns. In the first part, adult participants receive increasing doses of DON ranging from 0.1 to 10 mgkg intravenously, along with premedication using ondansetron to prevent nausea. Adults with uncomplicated malaria also receive standard antimalarial therapies. In the second part, children with cerebral malaria receive either DON at doses of 0.1 or 1.0 mgkg or placebo, alongside antimalarial treatments, across four cohorts with differing dose and randomization ratios. Pediatric participation spans three malaria seasons, with a total study duration of six months for both adults and children. Participants undergo safety evaluations including monitoring for adverse events and assessments of coma scores. Pharmacokinetic measurements of DON levels are taken up to 18 hours post-infusion. Children with cerebral malaria also have brain blood flow evaluated by transcranial Doppler, brain volume assessed by MRI, and brain activity recorded by EEG. Follow-up and safety monitoring continue for six months after dosing to assess the effects and tolerability of DON.

CONDITIONS

Brief Title

DON in Pediatric Cerebral Malaria

Research Team

Y

Yamikani Chimalizeni, MD

A

Alice Liomba

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here